Contact
searchSearch
HMP Global

Renal Denervation Topic Center

Featured

Renal Denervation
Medtronic Receives Approval for Symplicity Spyral Renal Denervation System in Japan
09/02/2025
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure...
09/02/2025
Cath Lab Digest
RDN approvals
Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension
08/25/2025
The Paradise uRDN system is a novel ultrasound-based renal denervation technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is a novel ultrasound-based renal denervation technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is a...
08/25/2025
Cath Lab Digest
Guidelines
Recor Medical Responds to the American Heart Association (AHA) and American College of Cardiology’s (ACC) Updated Guidelines on Renal Denervation for the Treatment of Hypertension
08/15/2025
“We are pleased to see that the strength of our RADIANCE Global Program formed the basis for the positive inclusion in the guidelines, which not only reinforce the credibility of this therapy—they directly align with the compelling clinical...
“We are pleased to see that the strength of our RADIANCE Global Program formed the basis for the positive inclusion in the guidelines, which not only reinforce the credibility of this therapy—they directly align with the compelling clinical...
“We are pleased to see that the...
08/15/2025
Cath Lab Digest
BP Readings
Blood Pressure Cuff Errors May Be Missing 30% of Hypertension Cases
08/15/2025
08/15/2025
Cath Lab Digest
Guidelines
Medtronic Announces 2025 American College of Cardiology / American Heart Association Updated Hypertension Guidelines for Renal Denervation; Procedure Now Recommended
08/15/2025
The new ACC/AHA hypertension guidelines classify renal denervation procedures - like those using the Medtronic Symplicity Spyral™ renal denervation system - as a class IIb recommendation. These guidelines follow earlier consensus statements...
The new ACC/AHA hypertension guidelines classify renal denervation procedures - like those using the Medtronic Symplicity Spyral™ renal denervation system - as a class IIb recommendation. These guidelines follow earlier consensus statements...
The new ACC/AHA hypertension...
08/15/2025
Cath Lab Digest
Paradise (Recor Medical)
Renal Denervation
Recor Medical Supports Proposed CMS National Coverage Determination of Renal Denervation for the Treatment of Hypertension
07/11/2025
The proposed National Coverage Determination (NCD), released on July 10, 2025, recommends coverage for ultrasound renal denervation (uRDN) and radiofrequency renal denervation (rfRDN) for uncontrolled hypertension. A 30-day public comment...
The proposed National Coverage Determination (NCD), released on July 10, 2025, recommends coverage for ultrasound renal denervation (uRDN) and radiofrequency renal denervation (rfRDN) for uncontrolled hypertension. A 30-day public comment...
The proposed National Coverage...
07/11/2025
Cath Lab Digest
Resistant Hypertension
First Patient Treated in Medtronic Multi-Organ SPYRAL GEMINI Pilot Study
07/07/2025
The first patient was treated by Dr. Barry Bertolet at Cardiology Associates of North Mississippi and North Mississippi Medical Center in Tupelo. With this trial, Medtronic intends to investigate the feasibility of combined denervation of...
The first patient was treated by Dr. Barry Bertolet at Cardiology Associates of North Mississippi and North Mississippi Medical Center in Tupelo. With this trial, Medtronic intends to investigate the feasibility of combined denervation of...
The first patient was treated by...
07/07/2025
Cath Lab Digest
Symplicity Spyral renal denervation
Study
Medtronic Treats First U.S. Patient in Global SYMPLICITY Registry DEFINE Study
06/11/2025
The GSR-DEFINE study is a prospective, all-comer observational extension of the broader Global SYMPLICITY Registry - the largest real-world study evaluating the long-term safety and effectiveness of Medtronic’s renal denervation (RDN) systems...
The GSR-DEFINE study is a prospective, all-comer observational extension of the broader Global SYMPLICITY Registry - the largest real-world study evaluating the long-term safety and effectiveness of Medtronic’s renal denervation (RDN) systems...
The GSR-DEFINE study is a...
06/11/2025
Cath Lab Digest
Interview
Renal Denervation: Patient Selection for Hypertension and Beyond
04/21/2025
Lindsay Machan, MD
VDM spoke with interventional radiologist Lindsay Machan, MD, from Vancouver Hospital in Canada, to discuss his presentation on selecting patients for renal denervation treatment.
VDM spoke with interventional radiologist Lindsay Machan, MD, from Vancouver Hospital in Canada, to discuss his presentation on selecting patients for renal denervation treatment.
VDM spoke with interventional...
04/21/2025
Vascular Disease Management
From Vascular Disease Management
Renal Denervation
4 Cases: Treating Uncontrolled Hypertension With the Paradise™ Ultrasound Renal Denervation System (uRDN)
04/04/2025
Surabhi Madhwal Atreja, MD, FACC, RPVI; Aravinda Nanjundappa MBBS, MD; Wissam Gharib, MD, FACC, FSCAI; Jordan King, MPAS, PA-C; Vamsee M. Yaganti, MD, MA, FACC, FSCAI
Cases shared by Surabhi Madhwal Atreja, MD, FACC, RPVI; Aravinda Nanjundappa, MBBS, MD; Wissam Gharib, MD, FACC, FSCAI, and Jordan King, MPAS, PA-C; and Vamsee Yaganti, MD, MA, FACC, FSCAI.
Cases shared by Surabhi Madhwal Atreja, MD, FACC, RPVI; Aravinda Nanjundappa, MBBS, MD; Wissam Gharib, MD, FACC, FSCAI, and Jordan King, MPAS, PA-C; and Vamsee Yaganti, MD, MA, FACC, FSCAI.
Cases shared by Surabhi Madhwal...
04/04/2025
Cath Lab Digest
Joachim Weil, MD
RF RDN
SPYRAL HTN-OFF and -ON MED 24-Month Results: BP Reductions After RF RDN
04/02/2025
Joachim Weil, MD
Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...
Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...
Joachim Weil, MD, presented a...
04/02/2025
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use